A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 100 participants.
Also called NCT02284737
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT02284737
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Terminated
Technical summary
Registry record NCT02284737. Randomized; single masking; primary purpose treatment. Start 2014-11-28 (actual); primary completion 2021-07-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH
- Acronym
- PADN-PAH
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Procedure)
- PADN
- Intervention (Procedure)
- sham PADN
- Intervention (Drug)
- Sildenafil
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
Record details
- Record id
cardio:ct-nct02284737- Content hash
c2df338e8f5fa16a3de6bfb77952c1ab220ff4708e50d0ce24ab4d0e0ee9e4f1